THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Cormorant Asset Management, LP's Holding History (CIK: 0001583977)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 300,000 Value ($000) $4,356 Avg Close $18.78 Range $14.46 - $22.74
Q1 2021
Shares 550,000 Value ($000) $11,226 Avg Close $19.01 Range $16.46 - $21.21
Q4 2020
Shares 550,000 Value ($000) $9,773 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 650,072 Value ($000) $9,611 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 100,000 Value ($000) $2,099 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 100,000 Value ($000) $2,311 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 50,000 Value ($000) $1,295 Avg Close $19.43 Range $15.72 - $26.47
Q4 2018
Shares 884,916 Value ($000) $22,645 Avg Close $27.00 Range $21.70 - $35.48
Q3 2018
Shares 1,100,000 Value ($000) $35,937 Avg Close $27.25 Range $22.26 - $32.79
Q2 2018
Shares 1,300,000 Value ($000) $29,484 Avg Close $23.74 Range $21.27 - $26.00
Q1 2018
Shares 1,300,000 Value ($000) $31,525 Avg Close $27.46 Range $22.90 - $30.29
Q4 2017
Shares 900,000 Value ($000) $25,101 Avg Close $29.59 Range $25.20 - $35.90
Q3 2017
Shares 950,000 Value ($000) $32,528 Avg Close $32.70 Range $23.15 - $42.61
Q2 2017
Shares 950,000 Value ($000) $37,848 Avg Close $38.45 Range $34.85 - $43.44
Q1 2017
Shares 1,425,000 Value ($000) $52,469 Avg Close $31.95 Range $27.80 - $37.18
Q4 2016
Shares 1,425,000 Value ($000) $45,429 Avg Close $31.02 Range $24.54 - $38.92
Q3 2016
Shares 1,118,372 Value ($000) $40,530 Avg Close $27.84 Range $21.97 - $37.14
Q2 2016
Shares 1,118,372 Value ($000) $25,376 Avg Close $21.59 Range $15.00 - $24.76